Potential Association of BRCA Mutation and Lymphocytic Lobulitis
Authors:
Open Access
- 24 October 2026
- journal article
- Published by Wiley in Clinical Case Reports
- Vol. 14 (11) , e73798
Abstract
Lymphocytic lobulitis (LL) is a rare fibroinflammatory breast lesion historically associated with long‐standing Type 1 diabetes mellitus and autoimmune conditions. Recent evidence suggests possible links between LL and hereditary breast cancer syndromes, particularly BRCA mutations. We present the case of a BRCA1 mutation carrier who developed bilateral lymphocytic lobulitis with B‐cell predominance, discuss its clinicopathologic features, and review current literature on the intersection of autoimmune, metabolic, and genetic risk pathways.Keywords
This publication has 5 references indexed in Scilit:
- Non-sclerosing (T-cell) and sclerosing (B-cell) lymphocytic lobulitis in diagnostic breast biopsies: Clinical, imaging, and pathologic featuresHuman Pathology, 2024
- Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriersBreast Cancer Research and Treatment, 2022
- Lymphocyte subsets contribute to the degree of lobulitis and ductitis in sclerosing lymphocytic lobulitis of the breastJournal of Clinical Pathology, 2015
- Lobulitis in nonneoplastic breast tissue from breast cancer patients: association with phenotypes that are common in hereditary breast cancerHuman Pathology, 2013
- Lymphocytic Mastitis and Diabetic Mastopathy: A Molecular, Immunophenotypic, and Clinicopathologic Evaluation of 11 CasesLaboratory Investigation, 2003